Category Specific RSS

biopharma

Special delivery: unique drug delivery system receives new US patent

Let’s rewind to Year 10 biology- you know that mitochondria is the powerhouse of the cell, chances are you vaguely…

4 years ago

Shareholders back Pharmaxis liver cancer treatment trials via oversubscribed capital raise

When the University of Rochester came knocking on the door of biopharmaceutical company Pharmaxis (ASX: PXS), it was a boost…

4 years ago

Bionomics granted Fast Track approval from FDA to study PTSD drug

Once upon a time, stress ensured our survival. When faced with a dangerous situation our body responds instantly- heart rate…

4 years ago

Pharmaxis streamlines operations with $2m sale of Australian distribution rights

Having successfully developed a number of drugs through to regulatory approval and commercial sales, Pharmaxis (ASX: PXS) is set to…

4 years ago

New Anatara trial to tackle anxiety, stress and depression with diet supplement

Working in conjunction with the CSIRO, Anatara Lifesciences (ASX: ANR) has received ethics approval to apply their diet supplement 3FDC…

4 years ago

FDA approves Imugene to commence human trial for lung cancer immunotherapy

Biopharma company Imugene (ASX: IMU) is now on their way towards commercialisation of their lung cancer treatment with approval from…

5 years ago